ES2089286T3 - Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos. - Google Patents

Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.

Info

Publication number
ES2089286T3
ES2089286T3 ES92108324T ES92108324T ES2089286T3 ES 2089286 T3 ES2089286 T3 ES 2089286T3 ES 92108324 T ES92108324 T ES 92108324T ES 92108324 T ES92108324 T ES 92108324T ES 2089286 T3 ES2089286 T3 ES 2089286T3
Authority
ES
Spain
Prior art keywords
amino
preparation
new
dihidropiridinas
ciano
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92108324T
Other languages
English (en)
Inventor
Jurgen Dipl-Ing Stoltefuss
Siegfried Dr Goldmann
Alexander Dr Straub
Horst Dr Boshagen
Martin Dr Bechem
Rainer Prof Dr Gross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2089286T3 publication Critical patent/ES2089286T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms

Abstract

LA PRESENTE INVENCION SE REFIEREN A UNA NUEVA 2 5 CIANO ENERAL I EN LA QUE R1, R2 Y R3 TIENEN LA SIGNIFICACION DADA EN LA DESCRIPCION DE PATENTE, PROCESO PARA SU FABRICACION Y UTILIZACION EN MEDICAMENTOS, ESPECIALMENTE EN MEDICAMENTOS PARA EL TRATAMIENTO DE ENFERMEDADES DEL CORAZON Y DE LA CIRCULACION.
ES92108324T 1991-05-30 1992-05-18 Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos. Expired - Lifetime ES2089286T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4117750A DE4117750A1 (de) 1991-05-30 1991-05-30 Neue 2-amino-5-cyano-1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Publications (1)

Publication Number Publication Date
ES2089286T3 true ES2089286T3 (es) 1996-10-01

Family

ID=6432811

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92108324T Expired - Lifetime ES2089286T3 (es) 1991-05-30 1992-05-18 Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.

Country Status (22)

Country Link
US (3) US5225558A (es)
EP (1) EP0515940B1 (es)
JP (1) JPH05186459A (es)
KR (1) KR920021530A (es)
AT (1) ATE140455T1 (es)
AU (2) AU656374B2 (es)
CA (1) CA2069860A1 (es)
CZ (1) CZ158692A3 (es)
DE (2) DE4117750A1 (es)
DK (1) DK0515940T3 (es)
ES (1) ES2089286T3 (es)
FI (1) FI922428A (es)
GR (1) GR3020575T3 (es)
HU (2) HUT61538A (es)
IE (1) IE921771A1 (es)
IL (3) IL102032A (es)
MX (1) MX9202366A (es)
NO (2) NO921906L (es)
NZ (2) NZ242932A (es)
RU (1) RU2081872C1 (es)
SK (1) SK158692A3 (es)
ZA (1) ZA923935B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2683819B1 (fr) * 1991-10-28 1994-02-11 Synthelabo Derives de quinoleine, leur procede de preparation et leur application en therapeutique.
ES2113933T3 (es) * 1991-11-12 1998-05-16 Coatex Sa Agente de trituracion y/o dispersion a base de polimeros y/o copolimeros neutralizados parcialmente por magnesio para suspensiones acuosas de materiales minerales para la aplicacion de pigmentos.
DE4233586A1 (de) * 1992-10-06 1994-04-07 Bayer Ag 3-Imino-3-alkoxy-propionsäurelactate und deren tautomere Acrylsäurelactate
DE4313693A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 2-Amino-4-chinolin-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung
DE4313695A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 2-Amino-5-cyano-4-chinolyldihydropyridinester, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4313691A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 2,6-Disubstituierte 4-Chinolyl-dihydropyridine
DE4313697A1 (de) * 1993-04-27 1994-11-03 Bayer Ag Chinolyl-dihydropyridinester, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4313696A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 2-Amino-4-heteroaryl-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4313692A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 3-Chinolyl substituierte Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4432378A1 (de) * 1994-09-12 1996-03-14 Bayer Ag Injizierbare liposomale Arzneizubereitungen

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2359329A (en) * 1943-06-18 1944-10-03 Burroughs Wellcome Co Quinoline substituted dihydropyridines
US4001258A (en) * 1972-03-06 1977-01-04 Bayer Aktiengesellschaft 2-amino-1,4-dihydropyridine derivatives
US3996234A (en) * 1972-04-18 1976-12-07 Bayer Aktiengesellschaft 1,4-Dihydropyridine carboxylic acid esters
DE2242786A1 (de) * 1972-08-31 1974-03-14 Bayer Ag Verfahren zur herstellung von neuen 2-amino-1,4-dihydropyridinen mit einer carbonylfunktion sowie ihre verwendung als arzneimittel
US3989708A (en) * 1972-08-31 1976-11-02 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
DE2310747A1 (de) * 1973-03-03 1974-09-12 Bayer Ag Verfahren zur herstellung von neuen amino-3,4-dihydropyridinen und ihre verwendung als arzneimittel
US4002762A (en) * 1973-03-03 1977-01-11 Bayer Aktiengesellschaft 2-Amino-3,4-dihydropyridines used to effect coronary vessel dilation and treat hypertension
DE2412750A1 (de) * 1974-03-16 1975-09-18 Bayer Ag Verfahren zur herstellung von 4-amino2,2,6,6-tetramethyl-piperidin
DE2623170C2 (de) * 1976-05-22 1982-03-11 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von α-Cyanzimtaldehyd-Derivaten und 3,4,5-Trimethoxy-α-Cyanzimtaldehyd
DE2658804A1 (de) * 1976-12-24 1978-07-06 Bayer Ag Kreislaufbeeinflussende mittel
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
DE3015219A1 (de) * 1980-04-19 1981-10-22 Bayer Ag, 5090 Leverkusen 6-amino-4,5-dihydropyridin-3-carbonsaeureester, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3134945A1 (de) * 1981-09-03 1983-03-17 Bayer Ag, 5090 Leverkusen Substituierte 2-amino-3,4-dihydropyridinderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimittel
US5001381A (en) * 1987-12-08 1991-03-19 Akio Takahashi Electro-static motor
DE4011105A1 (de) * 1990-04-06 1991-10-10 Bayer Ag Neue 4-chinolyl-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
SK158692A3 (en) 1995-03-08
FI922428A (fi) 1992-12-01
DE59206772D1 (de) 1996-08-22
US5432282A (en) 1995-07-11
NZ242932A (en) 1995-06-27
NO970573D0 (no) 1997-02-07
IL116384A (en) 1996-10-16
NO921906L (no) 1992-12-01
ZA923935B (en) 1993-02-24
CZ158692A3 (en) 1993-07-14
IE921771A1 (en) 1992-12-02
HUT61538A (en) 1993-01-28
HU9201799D0 (en) 1992-08-28
EP0515940A1 (de) 1992-12-02
DE4117750A1 (de) 1992-12-24
AU1604592A (en) 1992-12-03
US5225558A (en) 1993-07-06
IL102032A (en) 1996-06-18
IL116384A0 (en) 1996-03-31
RU2081872C1 (ru) 1997-06-20
US5380851A (en) 1995-01-10
DK0515940T3 (da) 1996-11-25
JPH05186459A (ja) 1993-07-27
HU211579A9 (en) 1995-12-28
FI922428A0 (fi) 1992-05-27
ATE140455T1 (de) 1996-08-15
MX9202366A (es) 1992-11-01
EP0515940B1 (de) 1996-07-17
NO970573L (no) 1992-12-01
IL102032A0 (en) 1992-12-30
NZ264151A (en) 1995-06-27
GR3020575T3 (en) 1996-10-31
AU1619995A (en) 1995-08-03
AU656374B2 (en) 1995-02-02
CA2069860A1 (en) 1992-12-01
NO921906D0 (no) 1992-05-14
KR920021530A (ko) 1992-12-18

Similar Documents

Publication Publication Date Title
IT8847956A0 (it) Benzo-b-pirani e piranopiridone, loro preparazione e loro impiego come medicamenti
EE04021B1 (et) 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
IT1219811B (it) Derivati peptidici,loro preparazione e loro impiego come medicamenti
DK1036058T3 (da) Adamantanderivater
DE69808130D1 (de) Adamantan-derivate
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
DK143588A (da) Substituerede 9-amino-tetrahydroacridiner, deres fremstilling og anvendelse som laegemidler
MX9102353A (es) N,o-sulfados de heparosanos, su procedimiento de preparacion y las composiciones farmaceuticas que contienen.
ATE239709T1 (de) Racemisches huperzin a
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
IT8847871A0 (it) Ne e loro impiego come medicamenti derivati peptidici,loro preparazio-
DE3582594D1 (de) Proglumid und dessen pharmazeutische zusammensetzungen zur anwendung bei der behandlung von neoplastischen affektionen.
TR200100637T2 (tr) Yeni doğal ürün türevleri
IT8721691A0 (it) Derivati dell'ossima della 1,2,5,6-tetraidropirdin-3-carbossaldeide, loro procedimento di preparazione e loro impiegocome sostanze medicinali.
DK366888A (da) Castanosperminestre og -glykosider, deres fremstilling og anvendelse som laegemidler
IT8721687A0 (it) Derivati dell'ossima della 1,2,5,6-tetraidropiridin-3-carbossa ldeide, loro procedimento di preparazione e loro impiego come sostanze medicinali.
DE68900926D1 (de) Pharmazeutische zubereitung, die zidovudin und inosiplex oder bestandteile davon enthaelt, fuer die behandlung von aids-verwandten syndromen.
IT8319600A0 (it) Composizioni farmaceutiche e loro uso nel trattamento del glaucoma.
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
DE68905076T2 (de) Pharmazeutische Zusammensetzung für die Behandlung von Hautwunden.
IT8721540A0 (it) Composizioni farmaceutiche contenenti trapidil, loro procedimento di preparazione erelativo impiego terapeutico.
IT1211681B (it) Peptidi e derivati peptidici, loro preparazione e loro impiego come medicamenti
TR199901385T2 (xx) Piperidin t�revleri.
ITMI922216A1 (it) Nitrobenzoilalanine, procedimento per la loro preparazione, loro uso come agenti terapeutici e composizioni farmaceutiche che le contengono
ATE59776T1 (de) Pharmazeutische zusammensetzung und behandlung.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 515940

Country of ref document: ES

FG2A Definitive protection

Ref document number: 515940

Country of ref document: ES